Major ear surgery, complex septorhinoplasty, revision sinus surgery, laryngectomy or tympanomastoid surgery
The recommendations below are appropriate for most patients undergoing major ear surgery, complex septorhinoplasty, revision sinus surgery, laryngectomy or tympanomastoid surgery. However, if a patient is undergoing major ear surgery, complex septorhinoplasty or revision sinus surgery, and the procedure is contaminated or dirty (see Centers for Disease Control and Prevention stratification of surgical wounds) or undertaken in the setting of current or recent infection, the optimal antibiotic regimen is uncertain. The patient may already be treated with antimicrobial therapy and the prophylaxis regimens recommended below may require adjustment; the choice of prophylaxis should be guided by recent culture and susceptibility test results—seek expert advice.
For prophylaxis for major ear surgery, complex septorhinoplasty, revision sinus surgery, laryngectomy or tympanomastoid surgery, use:
cefazolin 2 g (child: 30 mg/kg up to 2 g) intravenously, within the 60 minutes before surgical incision; intraoperative redosing may be required (see here ). Do not give additional doses once the procedure is completed1 surgical prophylaxis, ear nose and throat: except hearing implants cefazolin
PLUS
metronidazole 500 mg (child: 12.5 mg/kg up to 500 mg) intravenously, within the 120 minutes before surgical incision; intraoperative redosing may be required (see here ). Do not give additional doses once the procedure is completed1 surgical prophylaxis, ear nose and throat metronidazole
PLUS for patients undergoing laryngectomy who are colonised or infected with MRSA or at increased risk of being colonised or infected with MRSA (see Risk factors for infection with methicillin-resistant Staphylococcus aureus)
vancomycin (adult and child) 15 mg/kg up to 2 g intravenously, started within the 120 minutes before surgical incision (recommended rate 10 mg/minute)2; intraoperative redosing may be required (see here )1. surgical prophylaxis, ear nose and throat: except hearing implants vancomycin
For patients with immediate nonsevere or delayed nonsevere hypersensitivity to penicillins, the above regimens are suitable. See also Surgical antibiotic prophylaxis for patients with a penicillin or cephalosporin allergy.
For patients with immediate severe or delayed severe hypersensitivity to penicillins, use:
clindamycin 600 mg (child: 15 mg/kg up to 600 mg) intravenously, within the 120 minutes before surgical incision; intraoperative redosing may be required (see here ). Do not give additional doses once the procedure is completed1 surgical prophylaxis, ear nose and throat clindamycin
PLUS for laryngectomy or tympanomastoid surgery
gentamicin (adult and child) 2 mg/kg up to 180 mg intravenously over 3 to 5 minutes, within the 120 minutes before surgical incision34; intraoperative redosing is unlikely to be required (see here ). Do not give additional doses once the procedure is completed1. surgical prophylaxis, ear nose and throat gentamicin
For patients with immediate severe or delayed severe hypersensitivity to penicillins who are undergoing laryngectomy and are colonised or infected with methicillin-resistant Staphylococcus aureus (MRSA), or at increased risk of being colonised or infected with MRSA (see Risk factors for infection with methicillin-resistant Staphylococcus aureus), add vancomycin (see dosage above) to the above regimen. Vancomycin is not needed if clindamycin is expected to have adequate activity against MRSA based on local epidemiology or recent MRSA culture results.